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Abstract
Background: Web-based self-management enhancing programs have the potential to support patients with rheumatoid arthritis
(RA) in their self-management; for example, improve their health status by increasing their self-efficacy or taking their prescribed
medication. We developed a Web-based self-management enhancing program in collaboration with RA patients and professionals
as co-designers on the basis of the intervention mapping framework. Although self-management programs are complex interventions,
it is informative to perform an explorative randomized controlled trial (RCT) before embarking on a larger trial.
Objective: This study aimed to evaluate the efficacy of a Web-based self-management enhancing program for patients with
RA and identify outcome measures most likely to capture potential benefits.
Methods: A multicenter exploratory RCT was performed with an intervention group and a control group. Both groups received
care as usual. In addition, the intervention group received 12 months of access to a Web-based self-management program.
Assessment occurred at baseline, 6 months, and 12 months. Outcome measures included self-management behavior (Patient
Activation Measurement, Self-Management Ability Scale), self-efficacy (Rheumatoid Arthritis task-specific Self-Efficacy,
Perceived Efficacy in Patient-Physician Interaction), general health status (RAND-36), focus on fatigue (Modified Pain Coping
Inventory for Fatigue), and perceived pain and fatigue (Numeric Rating Scales). A linear mixed model for repeated measures,
using the intention-to-treat principle, was applied to study differences between the patients in the intervention (n=78) and control
(n=79) groups. A sensitivity analysis was performed in the intervention group to study the influence of patients with high (N=30)
and low (N=40) use of the intervention.
Results: No positive effects were found regarding the outcome measurements. Effect sizes were low.
Conclusions: Based on these results, it is not possible to conclude on the positive effects of the intervention or to select outcome
measures to be regarded as the primary/main or secondary outcomes for a future trial. A process evaluation should be performed
to provide more insight into the low compliance with and effectiveness of the intervention. This can determine for whom this
sort of program will work and help to fine-tune the inclusion criteria.
Trial Registration: Netherlands Trial Register NTR4871; https://www.trialregister.nl/trial/4726
J Med Internet Res 2019 | vol. 21 | iss. 4 | e12463 | p.1https://www.jmir.org/2019/4/e12463/
(page number not for citation purposes)
Zuidema et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
(J Med Internet Res 2019;21(4):e12463)   doi:10.2196/12463
KEYWORDS
self-management; internet; arthritis, rheumatoid
Introduction
Background
Rheumatoid arthritis (RA) is one of the most prevalent chronic
conditions, with a pervasive impact on daily life [1]. Despite
the introduction of biological therapies and conventional
disease-modifying antirheumatic drugs, RA patients experience
a high level of pain [2] and fatigue [3,4], which leads to
disabilities like restrictions in work participation [5,6] and
leisure activities [7-9]. Moreover, many RA patients experience
disease-related psychological problems, like depressive mood
and helplessness [10,11].
To optimally manage the consequences of RA and reduce the
impact of the disease on patients in daily life, effective
self-management programs are needed. Web-based
self-management programs can easily reach a large group of
RA patients in their own place and time and provide more
anonymity than face-to-face programs. Studies have shown that
patients feel more comfortable sharing sensitive information
like reports on daily activity or feelings online [12]. Other
advantages are the possibility of tailoring information, avoiding
waiting lists, and 24-hour availability [13].
Studies about Web-based self-management programs have
shown to be effective in RA patients on several health outcomes,
including increased self-efficacy, knowledge and physical
activity [14], less pain, disability and depression, and reduction
in the overuse of medication and the number of visits to
physicians [15-17]. However, many of the programs are
developed without end-user involvement. Consequently, these
programs may not suit patient support needs for
self-management as patient preferences for program use are not
well known [18,19].
To guarantee optimal patient involvement, we developed a
Web-based self-management program on the basis of
intervention mapping (IM), called Reuma zelf te lijf (Coping
with RA) [20-22]. According to the Medical Research Council
(MRC), complex interventions such as this program can be
evaluated in a randomized controlled trial (RCT); however, it
is advised to first perform an explorative study investigating
potential outcome measurements to be used in a larger trial [23].
Objectives
Therefore, the present explorative RCT study in patients with
RA was aimed as follows: (1) to explore the potential efficacy
of a Web-based self-management enhancing program versus
“usual care” on self-management behavior, self-efficacy, general
health status, coping with fatigue and the level of pain and
fatigue and to determine the effect sizes at 6 and 12 months
after baseline, and (2) to identify outcome measures most likely
to capture the potential benefits covered by the performance
objectives, by exploring their floor and ceiling effects at
baseline.
Methods
Design
A multicenter exploratory RCT was conducted in 2 Dutch
hospitals, The Radboudumc (a University hospital) and the Sint
Maartenskliniek (a specialized hospital in rheumatology,
rehabilitation, and orthopedic surgery), both located in
Nijmegen, the Netherlands. An intervention and a control group
were compared at 6 and 12 months after baseline on 6 outcome
measurements to explore the efficacy of the Web-based program
and to identify outcome measures [20]. The trial is registered
at the Netherlands Trial Register (ID: NTR4871).
Ethical Approval
The medical ethics committee of Arnhem-Nijmegen approved
this study (No. 2014-1208).
Participants
Between December 2014 and June 2015, patients with a
diagnosis of RA aged 18 years or older were invited by a letter
to participate in this study, in collaboration with rheumatologists,
until the required number of 190 patients was reached. Patients
received the following: (1) information about the study, (2) a
questionnaire for screening eligibility, and (3) an informed
consent form. Eligibility criteria were the ability to speak and
read Dutch and having access to a computer with an internet
connection. Patients receiving psychiatric or psychological
treatment were excluded. Patients willing to participate were
asked to return the informed consent with the completed
questionnaire. When patients agreed to participate and were
eligible, the researcher sent the patient an email with the baseline
questionnaire.
Randomization
Eligible patients were stratified by the hospital and randomly
assigned to the intervention or control group by an independent
statistician using an automated randomization program. The
researcher informed the patients by post if they were allocated
to the control or intervention group. Patients in the control group
continued with their care as usual, which comprised medical
treatment at the outpatient clinic. The patients in the intervention
group received, in additional to their care as usual, 12 months
of access to the intervention directly after randomization.
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Table 1. Overview of the 9 modules and their performance objectives.
Performance objective: Patients need to...Module name
...find balance between rest and activity; make choices when participating in daily life activities to keep
balance
Balancing activity and rest
...set boundaries for their partner, relatives, colleagues and social environmentSetting boundaries
...ask for social support or practical help from their partner, relatives, colleagues and social environment
in daily life; ask for social support and practical help from colleagues; accept receiving social support
or practical help from their partner, relatives, colleagues and social environment in daily life
Asking for help and social support
...take prescribed medicationUse of medicines
...prepare for a visit to a health professional; ask questions and/or express concerns during an appointment
with a health professional
Communication with health professionals
...use, if necessary, assistive devicesUse of assistive devices
...perform daily physical exercisesPerforming physical exercises
...cope with worries about RAaCoping with worries
...cope with RACoping with RA
aRA: rheumatoid arthritis.
Intervention
Web-Based Self-Management Enhancing Program
The intervention was developed between January 2013 and July
2014 in collaboration with RA patients and professionals as
co-designers [20,24]. The theory of planned behavior was used
as the underlying theory and essential behavioral change
techniques were applied to induce behavioral change formulated
as performance objectives, selected according to the IM steps
[21,25,26]. The Web-based self-management enhancing program
comprises 9 modules with 13 performance objectives (Table 1)
and a diary to track patients’ fatigue and pain over time [20].
Each module comprises 2-5 sessions, with informational and
persuasive texts, videos with instructions and role models,
exercises, and assignments. The program is unguided, and
patients need to choose a module by their own and can work
through it at their own pace whenever they want.
Implementation of the Web-Based Self-Management
Enhancing Program
To implement the Web-based program and to increase use of
the program by patients, 3 implementation strategies were
deployed during the study: (1) patients received a written
instruction manual for the program, (2) reminders to (re)visit
the program were sent twice weekly via email, and (3) nurses
brought the program to the attention of the intervention group
participants during their consultation.
Measurements and Outcomes
All included patients who filled in the baseline questionnaire
between January 2015 and June 2015 received a questionnaire
after 6 months (T1) and 12 months (T2). At baseline,
demographic and disease characteristics were assessed.
Patient-reported outcome measurements were assessed at
baseline and during follow-ups (T1 and T2). When patients
preferred a paper questionnaire, a version was sent by post.
When patients did not return the questionnaire at T1 but filled
in the questionnaire at T2, this was indicated as a missing value
at T1. Patients who did not return the T2 questionnaire are
indicated as dropouts.
Baseline Characteristics
The following demographic and disease characteristics were
assessed: age, gender, education level, employment status,
disease duration, Numeric Rating Scales (NRS) pain/fatigue,
Modified Health Assessment Questionnaire (M-HAQ) physical
disability, and satisfaction with health status. The M-HAQ
comprises 8 questions on difficulties in daily activities in the
following domains: dressing, rising, eating, walking, hygiene,
reaching, gripping, and usual activities. Patients responded on
a 4-point scale, with a higher score indicating more difficulty
in performing daily activities. Health satisfaction was assessed
using 1 question about patients’ (dis)satisfaction about the course
of their disease last week, with 4 response options, with a higher
score meaning less satisfied than before and an “I don't know”
option [27].
Outcome Measurements
Based on the theory of planned behavior, 6 outcome measures
were relevant: self-management behavior, self-efficacy, general
health status, coping with fatigue, and the level of pain and
fatigue.
Self-Management Behavior
The Patient Activation Measurement (PAM-13) includes
statements about individuals’ knowledge, confidence, and skills
for self-management of their chronic illness behavior and the
level of activation. It includes 13 items on a 5-point scale with
a higher score indicating a higher level of patient activation.
The scores of the 13 items are summarized as a total score. Total
PAM scores were computed if at least 10 items were completed
[28].
The short Self-Management Ability Scale (SMAS-S) comprises
18 items scored on a 6-point scale with a higher score indicating
better self-management behavior [29].
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Self-Efficacy
The Rheumatoid Arthritis task-specific Self-Efficacy (RASE)
questionnaire comprises 28 items scored on a 5-point Likert
scale. Higher scores reflect higher self-efficacy [30]. This
questionnaire was translated into Dutch via forward-backward
translation and decisions were based on consensus with a group
of 5 researchers, 4 RA patients, and 1 RA patient who was a
native English speaker. The Perceived Efficacy in
Patient-Physician Interaction (PEPPI-5) comprises a 5-point
Likert scale. A higher score reflects more confidence in patient
interactions with their physician [31].
General Health Status
The RAND-36 comprises 36 questions measuring 8 dimensions:
physical functioning, social functioning, physical role
limitations, emotional role limitations, mental health, vitality,
pain, perceived health-related quality of life and behavioral
change, with various response options based on 3- to 6-point
Likert scales, with a higher score indicating better perceived
health-related quality of life. Scores were transformed to a
0-100-point scale for each subscale [32].
Level of Pain and Fatigue
Pain and fatigue were measured with NRS, ranging from 0 to
10 with 0 indicating no pain/fatigue and 10 indicating severe
pain/very tired. For both outcomes, 2 questions were asked: the
level of pain/fatigue today and the mean level of pain/fatigue
during the last 2 weeks.
Coping with Fatigue
The Modified Pain Coping Inventory for Fatigue (MPCI-F) was
used. This questionnaire is based on a subscale of the Pain
Coping Inventory questionnaire and modified to assess coping
with fatigue instead of coping with pain [33]. The questionnaire
comprises 8 items to assess the focus on fatigue. A higher score
reflects more focus on fatigue.
Statistical Analysis
Descriptive statistics were used to describe the control and
intervention groups at baseline. t tests and Chi-square tests were
used to analyze baseline differences. It was analyzed whether
the patients who dropped out differed from the group that
returned the questionnaire at T2 [34]. Between-group differences
in outcomes were analyzed using a linear mixed model to
account for repeated measurements and to handle missing data
under the missing-at-random assumption. Differences between
the intervention and control groups were analyzed at baseline,
after 6 months (T1), and 12 months (T2). The fixed variables
in the model were as follows: group (intervention/control),
hospital (hospital 1 or hospital 2), age, gender, disease duration,
education level, employment status, physical functioning
(M-HAQ), and the interaction terms between measurement time
points and groups. The first analysis was done using the
intention-to-treat principle. Subsequently, a sensitivity analysis
was performed to explore the influence of program use within
the intervention group. The intervention group was divided into
3 groups: (1) a group with low usage (0-1 visits), (2) a group
with moderate usage (2-5 visits), and (3) a group with high
usage (6 or more visits). In the analysis, the group with moderate
usage was left out to increase the contrast between the groups
with low and high usage. t tests and Chi-square tests were
performed to analyze between-group differences in
demographics, disease-related characteristics, and outcomes at
baseline, T1, and T2. Statistical significance was defined as
P<.05.
For all outcome measurements, Cohen d was used to quantify
effect sizes by calculating the difference in means, divided by
the pooled within-group standard deviation [35]. Following
Cohen definition of effect sizes, less than 0.4 was defined as a
small effect, between 0.5 and 0.7 as moderate, and ≥0.8 was
considered as a large effect [36]. Floor and ceiling effects were
explored for all outcome measures by examining the percentage
of minimum and maximum scores, which reflects the extent
that patients scored the lowest or the highest score. For a 3- or
5-point Likert scale, floor and ceiling effects were defined as
more than 80% of the patients scoring the lowest/highest.
Statistical analyses were performed using SPSS version 22
(SPSS Inc) for Windows. For exploratory RCT such as these,
sample sizes are not calculated based on formal power analyses.
For this trial, a sample size of 200 patients was chosen, which
was considered a sufficient size for a representation of the
relevant variation in the target group.
Results
Overview
In total, 669 patients were eligible and invited. Of these, 191
patients expressed interest and 189 met the inclusion criteria
(see Figure 1). In total, 157 patients completed the baseline
questionnaire between January 2015 and June 2015. These
patients were randomly assigned to the intervention group
(n=78) and the control group (n=79), stratified by hospital. At
T1, 59 in the intervention group and 65 in the control group
filled in the questionnaire. At T2, 54 patients in the intervention
group and 74 patients in the control group completed the
questionnaire. Overall, in the intervention group, few patients
(69%, 54/78) participated at T2 than in the control group (94%,
74/79). Most of these patients gave the burden of their illness
as the reason for dropout. Some patients refused to fill in the
questionnaire at T1 but completed the questionnaire at T2, which
explains the higher number of patients who filled in the
questionnaire at T2 compared with T1. Differences in
demographics and disease-related characteristics between the
group of patients who refused to fill in the questionnaire at T2
and the group who returned the questionnaire at T2 were small
(<10%), which indicated that dropout did not influence the
outcomes.
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Figure 1. CONSORT flow diagram.
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Table 2. Demographics and disease-related characteristics at baseline.
Intervention groupControl groupCharacteristics
StatisticsNStatisticsN
61.0 (11.3)62.9 (10.2)Age (years), mean (SD)
Gender, %
35273427Men
65516652Women
9 (5.0, 19.5)7717 (6.0, 26)79Disease duration, median (25th, 75th percentiles)
Education level, %
13103528Low
55433528Medium
32252923High
Employment status, %
53416350Not working
9797Part-time working
39302822Working
0.6 (0.1, 1.1)780.5 (0.1, 1.4)79Physical disability (M-HAQa), median (25th, 75th percentiles)
3.2 (2.2)773.3 (2.3)79NRS pain today, mean (SD)
3.6 (2.3)783.9 (2.3)79NRS mean pain last 2 weeks, mean (SD)
3.8 (2.4)784.1 (2.5)79NRS fatigue today (NRS), mean (SD)
4.3 (2.3)784.3 (2.4)79NRS mean fatigue last 2 weeks, mean (SD)
aM-HAQ: Modified Health Assessment Questionnaire.
Baseline Characteristics of Patients
Demographics and disease-related characteristics at baseline
were compared for the control group and the intervention group,
as shown in Table 2. The only significant between-group
difference in the patient characteristics was education level
(P=.003). Fewer patients in the intervention group had a lower
education level (12.8% vs 35.4%) and more patients had a
moderate (55.1% vs 35.4%) or higher education level (32.1%
vs 29.1%). Some patients who filled in a paper questionnaire
did not complete all items, which explains the missing data in
Tables 3 and 4.
The Outcome Measurements at Baseline and Follow-up
Table 3 gives an overview of the mean scores of outcome
measurements of the patients in the intervention and control
groups at baseline and after 6 and 12 months. The baseline
scores of the 2 groups did not differ significantly.
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Table 3. Mean scores of outcome measurements on baseline, T1 and T2 of control and intervention groups.
T2T1Baseline (T0)Scales, group
Mean (SD)NMean (SD)NMean (SD)N
PAMa (10-65)
47.8 (3.8)4547.7 (4.8)4946.9 (4.9)57Control
47.8 (2.9)3146.7 (6.9)3547.2 (3.7)47Intervention
SMAS-Sb (0-60)
37.6 (6.8)7437.9 (6.8)7536.0 (6.3)79Control
38.8 (7.0)5439.4 (6.4)5736.7 (7.1)78Intervention
RASEc (28-140)
99.9 (11.6)74101.5 (10.6)7599.4 (12.7)79Control
102.0 (7.4)54101.9 (10.3)57102.9 (10.2)78Intervention
PEPPI-5d (5-25)
20.6 (3.4)7321.0 (3.2)7521.6 (3.0)79Control
20.8 (3.1)5421.3 (3.1)5721.2 (3.3)78Intervention
RAND physical functioning (0-100)
61.8 (25.9)7459.4 (26.5)7558.1 (27.0)78Control
65.9 (26.7)5465.9 (27.3)5761.7 (26.1)77Intervention
RAND social functioning (0-100)
73.1 (22.4)7472.7 (22.3)7573.3 (2476)79Control
70.8 (24.3)5477.0 (19.6)5771.3 (20.8)78Intervention
RAND physical role limitations (0-100)
49.0 (43.1)7451.11 (45.3)7549.1 (43.6)79Control
49.1 (44.2)5457.9 (42.0)5649.0 (43.3)78Intervention
RAND emotional role limitations (0-100)
78.8 (39.2)7484.9 (35.2)7375.1 (40.5)79Control
78.4 (37.3)5485.2 (31.5)5480.1 (36.4)77Intervention
RAND mental health (0-100)
76.1 (14.6)7472.6 (16.7)7554.7 (14.3)78Control
75.9 (13.8)5476.5 (12.0)5652.6 (13.4)78Intervention
RAND vitality (0-100)
56.3 (21.2)7453.9 (21.6)7551.2 (22.7)78Control
62.5 (14.5)5461.2 (15.1)5653.1 (19.4)78Intervention
RAND pain (0-100)
66.1 (21.8)7460.8 (22.2)7559.9 (21.3)79Control
63.9 (22.1)5467.1 (21.0)5764.3 (22.3)78Intervention
RAND general health perception (0-100)
48.1 (17.5)7247.8 (18.3)7552.5 (18.7)79Control
50.4 (19.1)4852.3 (19.5)5752.7 (20.8)77Intervention
RAND health change (0-100)
44.3 (19.7)7450.3 (19.9)7544.9 (21.2)79Control
43.5 (23.9)5451.3 (20.8)5747.8 (23.2)78Intervention
NRSe pain today (0-10)
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T2T1Baseline (T0)Scales, group
Mean (SD)NMean (SD)NMean (SD)N
3.0 (2.2)723.2 (2.2)753.3 (2.3)79Control
3.3 (2.3)483.0 (2.3)573.2 (2.2)77Intervention
NRS mean pain last 2 weeks (0-10)
3.6 (2.2)723.8 (2.1)753.9 (2.3)79Control
3.9 (2.4)483.4 (2.3)573.6 (2.3)78Intervention
NRS fatigue today (0-10)
3.7 (2.3)723.8 (2.6)754.1 (2.5)79Control
3.6 (2.4)483.4 (2.4)573.8 (2.4)78Intervention
NRS mean fatigue last 2 weeks (0-10)
4.2 (2.4)724.2 (2.6)754.3 (2.4)79Control
4.0 (2.2)483.7 (2.1)574.3 (2.3)78Intervention
MPCI-Ff (4-32)
13.6 (4.3)7414.1 (4.7)7514.1 (4.8)79Control
13.6 (3.2)5413.3 (3.3)5714.1 (3.9)78Intervention
aPAM: Patient Activation Measurement.
bSMAS-S: short Self-Management Ability Scale.
cRASE: Rheumatoid Arthritis Self-Efficacy.
dPEPPI-5: Perceived Efficacy in Patient-Physician Interaction.
eNRS: numerical rating scale.
fMPCI-F: Modified Pain Coping Inventory for Fatigue.
In Table 4, the estimated differences between the intervention
and control groups of the intention-to-treat analysis at 6 and 12
months are presented. Overall, the scores show no significant
differences and small effect sizes. Only the outcome
measurement of the subscale RAND-36 vitality at T2 (5.41 95%
CI 0.16-10.65, P=.04) showed a significant difference with
respect to T0, with a small effect size (Cohen d) of 0.01 in favor
of the intervention group. Floor and ceiling effects were explored
for all specified outcomes at baseline but were not found.
Sensitivity Analysis
Baseline Characteristics of Patients
High users of the intervention scored statistically significantly
better than low users of the intervention on the following
baseline characteristics: physical disability (M-HAQ; P=.03),
RAND-36 subscale social functioning (P=.02), RAND-36
subscale physical role limitations (P=.03), RAND-36 pain
(P=.03), and all the NRS scales, that is, pain today (P=.002),
mean pain last 2 weeks (P=.02), fatigue today (P<.001) and
mean fatigue last 2 weeks (P<.001; see Table 5).
After performing the sensitivity analysis, a statistically
significant effect was found for the group with high usage on
the subscale RAND-36 general health perception after 12 months
(9.65, 95% CI 0.83-18.48, P=.03), with a small effect size of
0.02 (Table 6). No floor and ceiling effects were found for any
of the specified outcomes at baseline in the groups with low or
high usage.
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Table 4. The estimated group differences between intervention and control groups after intention-to-treat analysis at 6 months and 12 months after
baseline.
12 months after baseline6 months after baselineScales
Cohen dP valuea95% CIT0-T2
change
Cohen dP valuea95% CIT0-T1
change
0.00.93–1.6 to 1.5–0.10.0.44–3.4 to 1.5–0.7PAMb (10-65)
0.03.43–1.1 to 2.50.70.0.72–1.4 to 2.00.3SMAS-Sc (0-60)
0.00.81–2.2 to 2.90.30.0.16–4.9 to 0.8–2.1RASEd (28-140)
0.03.51–0.7 to 1.30.30.0.40–0.5 to 1.20.4PEPPI-5e (5-25)
0.00.96–5.4 to 5.1–0.20.00.40–3.3 to 8.12.5RANDf physical functioning (0-100)
–0.01.42–9.2 to 3.8–2.70.0.15–1.5 to 9.64.1RAND social functioning (0-100)
0.00.65–14.9 to 9.3–2.80.00.38–7.0 to 18.25.6RAND physical role limitations (0-100)
0.00.53–16.0 to 8.3–3.90.00.56–14.1 to 7.6–3.2RAND emotional role limitations (0-100)
0.00.66–3.0 to 4.70.90.0.16–1.1 to 6.82.8RAND mental health (0-100)
0.01.04g0.2 to 10.75.40.0.17–1.5 to 8.33.4RAND vitality (0-100)
–0.01.06–12.5 to 0.4–6.10.0.42–3.7 to 8.92.6RAND pain (0-100)
0.00.98–4.5 to 4.4–0.10.0.33–2.2 to 6.72.2RAND general health perception (0-100)
0.00.72–9.0 to 6.2–1.40.00.97–6.8 to 7.10.1RAND health change (0-100)
0.10.13–0.1 to 1.20.50.00.97–0.6 to 0.70.0NRSh pain today (0-10)
1.13.600.0 to 1.40.70.00.97–0.7 to 0.60.0NRS mean pain last 2 weeks (0-10)
0.01.46–0.4 to 0.90.30.0.66–0.5 to 0.80.2NRS fatigue today (0-10)
0.00.81–0.6 to 0.70.1–0.1.45–0.9 to 0.4–0.23NRS mean fatigue last 2 weeks (0-10)
0.01.58–0.7 to 1.20.30.00.90–0.8 to 0.90.1MPCI-Fi (4-32)
aValues represent outcomes of the ITT analysis without confounders. After adding confounders, no changes in values appear.
bPAM: Patient Activation Measurement.
cSMAS-S: short Self-Management Ability Scale.
dRASE: Rheumatoid Arthritis Self-Efficacy.
ePEPPI-5: Perceived Efficacy in Patient-Physician Interaction.
fRAND-36: General Health Status.
gSignificant differences (P<.05) between control and intervention groups.
hNRS: numerical rating scale.
iMPCI-F: Modified Pain Coping Inventory for Fatigue.
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Table 5. Scores at baseline for the groups with a low and high usage of the intervention: demographic characteristics, disease-related characteristics,
and outcome measures.
P valueHigh usageLow usageCharacteristics and outcome measures at baseline
StatisticsNStatisticsN
.0658.9 (10.8)4063.8 (10.5)29Age (years), mean (SD)
.55Gender, %
35143310Men
65266720Women
.808,5 (5,0, 18,7)408,0 (4,5, 22,5)29Disease duration, (median (25th, 75th percentiles))
.78Education level, %
135103Low
55226319Middle
3313288High
.28Employment status, %
58237322Not working
4317278Working
.03a0.5 (0.1, 1,0)401.1 (0.2, 1.6)a30Physical disability (Modified Health Assessment Questionnaire),
(median [25th, 75th percentiles])
.1146.2 (3.8)2048.0 (3.3)20PAMb (10-65), mean (SD)
.4837.7 (7.0)4036.5 (7.3)30SMAS-Sc (0-60), mean (SD)
.58103.4 (9.1)40102.1 (10.9)30RASEd (28-140), mean (SD)
.6821.2 (2.8)4021.5 (3.9)30PEPPI-5e (5-25), mean (SD)
.0766.3 (24.6)4054.3 (28.3)29RANDf physical functioning (0-100), mean (SD)
.02a77.8 (17.1)4064.6 (24.8)30RAND social functioning (0-100), mean (SD)
.03a60.0 (42.7)4036.7 (43.9)30RAND physical role limitations (0-100), mean (SD)
.2485.8 (33.7)4074.7 (41.5)29RAND emotional role limitations (0-100), mean (SD)
.0678.7 (11.6)4072.1 (16.1)30RAND mental health (0-100), mean (SD)
.0861.7 (15.4)4053.1 (22.9)30RAND vitality (0-100), mean (SD)
.03a69.8 (19.2)4056.9 (25.5)30RAND pain (0-100), mean (SD)
.0854.0 (17.6)4046.0 (19.4)29RAND general health perception (0-100), mean (SD)
.1052.5 (24.6)4043.3 (20.7)30RAND health change (0-100), mean (SD)
.002a2.5 (1.8)404.3 (2.5)29NRSg pain today (0-10), mean (SD)
.02a3.1 (2.1)404.4 (2.5)30NRS mean pain last 2 weeks (0-10), mean (SD)
<.001a3.0 (2.2)404.8 (2.4)30NRS fatigue today (0-10), mean (SD)
<.001a3.0 (2.2)404.8 (2.4)30NRS mean fatigue last 2 weeks (0-10), mean (SD)
.0813.2 (3.0)4015.0 (4.8)30MPCI-Fh (4-32), mean (SD)
aSignificant differences (P<.05) between the group low and high users.
bPAM: Patient Activation Measurement.
cSMAS-S: short Self-Management Ability Scale.
dRASE: Rheumatoid Arthritis Self-Efficacy.
ePEPPI-5: Perceived Efficacy in Patient-Physician Interaction.
fRAND-36: General Health Status.
gNRS pain/fatigue: Numeric Rating scales pain/fatigue.
hCoping with fatigue: Modified Pain Coping Inventory for Fatigue.
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Table 6. The estimated difference between the group with low and high usage of the intervention after sensitivity analysis at 6 months and 12 months
after baseline.
12 months after baseline6 months after baselineScales
Cohen dP valuea95% CIT0-T2
change
Cohen dP valuea95% CIT0-T1
change
0.00>.99–2.9 to 2.90.00.12.24–1.7 to 6.42.4PAMb (10-65)
0.02.44–2.0 to 4.51.30.00.82–3.4 to 2.7–0.4SMAS-Sc (0-60)
0.00.81–5.3 to 4.1–0.6–0.00.52–6.8 to 3.4–1.7RASEd (28-140)
0.00.93–1.9 to 1.7–0.1–0.11.20–2.5 to 0.5–1.0PEPPI-5e (5-25)
0.00.65–7.4 to 11.82.20.01.07–0.7 to 19.29.2RANDf physical functioning (0-100)
0.01.38–6.7 to 17.45.30.00.76–8.4 to 11.41.5RAND social functioning (0-100)
0.00.74–18.6 to 25.93.70.00.51–14.7 to 29.57.4RAND physical role limitations (0-100)
0.00.88–24.5 to 21.0–1.70.01.11–3.6 to 35.716.1RAND emotional role limitations (0-100)
–0.02.24–11.2 to 2.8–4.20.00.83–6.3 to 7.90.8RAND mental health (0-100)
0.00.81–10.8 to 8.4–1.20.01.50–5.6 to 11.52.9RAND vitality (0-100)
0.02.14–3.0 to 20.68.80.00.77–4.5 to 12.91.7RAND pain (0-100)
0.02.03g0.8 to 18.59.70.01.48–5.1 to 10.82.9RAND general health perception (0-100)
0.01.38–7.9 to 20.66.40.02.19–4.0 to 20.58.3RAND health change (0-100)
–0.11.41–1.9 to 0.8–0.60.00>.99–1.2 to 1.20.0NRSh pain today (0-10)
–0.16.24–2.3 to 0.60.9–0.12.29–1.8 to 0.5–0.6NRS mean pain last 2 weeks (0-10)
–0.14.22–2.2 to 0.5–0.90.03.73–1.0 to 1.30.2NRS fatigue today (0-10)
–0.08.51–1.7 to 0.8–0.50.03.78–1.0 to 1.30.2NRS mean fatigue last 2 weeks (0-10)
–0.01.67–2.1 to 1.3–0.4–0.01.76–1.7 to 1.3–0.2MPCI-Fi (4-32)
aValues represent outcomes of the ITT analysis without confounders. After adding confounders, no changes in values appear.
bPAM: Patient Activation Measurement.
cSMAS-S: short Self-Management Ability Scale.
dRASE: Rheumatoid Arthritis Self-Efficacy.
ePEPPI-5: Perceived Efficacy in Patient-Physician Interaction.
fRAND-36: General Health Status.
gSignificant differences (P<.05) between control and intervention groups.
hNRS: numerical rating scale.
iMPCI-F: Modified Pain Coping Inventory for Fatigue.
Discussion
Principal Findings
This study aimed to evaluate the efficacy of a Web-based
self-management enhancing program in patients with RA in an
explorative trial on 6 outcomes: self-management behavior,
self-efficacy, general health status, coping with fatigue, and the
level of pain and fatigue. Results show no remarkable
statistically significant difference between the intervention and
control group. Moreover, effect sizes were low. Consequently,
the results of this exploratory show no convincing trend
regarding the efficacy of the program. This was unexpected as
the theory-based intervention was carefully designed, according
the IM steps, on the basis of patients support needs [37,38]. In
addition, the range of outcome measures were selected carefully,
and the study was well-performed. Randomization was
successful, and the number of missing was limited. It was
thought that the size was adequate for a pilot study (N=157).
Notably, the lack of a trend for a positive result is not in line
with other studies, showing that self-management programs
seem to be promising for patients with a chronic illness,
including arthritis [15,35]. However, these studies cannot be
compared with each other in a straightforward manner because
of the various self-management approaches (eg, offering weekly
vs nonweekly Web-based courses, with face-to-face help or
without), various contents of the self-management programs,
and the different outcome measures used in these studies [15,39].
For example, it is unexpected that our Web-based program
yielded no results for RA patients, whereas the Web-based
program evaluated by Lorig and colleagues [14] concluded that
RA patients showed increased self-efficacy and improved health
status for 4 of the 6 health status measures that were included
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[14]. These different results may be explained by the different
questionnaires used for the same outcomes, that is, self-efficacy
and health status.
Moreover, differences in the content and delivery of the
programs could be a reason for the different results. Other
programs focused on different topics (eg, pain/stress
management, problem solving and nutrition, which were not
covered by our program). In our program, patients received no
help with logging into the program or using the program in
contrast to the program described by Lorig et al [14], where
patients received help and were encouraged to use the program.
Patients could choose which modules to work through and
follow it at their own speed. In the program described by Lorig
et al [14], peer moderators helped patients log in and encouraged
them to use the weekly program and moderate posts that patients
could leave on the program website [14].
There are potentially 5 reasons for the lack of efficacy of our
Web-based program: (1) the use of inappropriate outcome
measures, (2) individual patients had no need for
self-management support, (3) low usage of the program/high
dropout of the intervention group, (4) inadequate embedding
of the program in health care, and (5) not selecting the
appropriate patients.
First, in the case of inappropriate outcome measures, it could
be that the carefully selected validated questionnaires still did
not exactly measure the pursued behavior changes formulated
in the performance objectives. That is, the intervention aimed
to result in specific self-management behaviors. The validated
questionnaires comprised more generic questions and therefore
did not exactly measure these specifically formulated behavioral
changes in performance objectives (Table 1). However, it was
expected that a positive significant result would be found on
the RASE questionnaire, as this measures task-specific
self-efficacy for patients with RA with items closely related to
the specific formulated performance objectives. Finding no
positive results suggests that it is possible that our intervention
did not support patients in increasing their level of self-efficacy.
This could mean that the absence of positive results is less driven
by the choice of outcomes than by the other points discussed
below.
Second, it could be that recruited patients did not have a
perceived need for enhancing self-efficacy when they agreed
to participate in the program. Although the program was
developed on the basis of the support needs for self-management
of RA patients, individual participating patients in this study
were not asked whether, and if yes, what kind of support needs
they had for self-management. It could be that patients differ
in their needs and more tailoring toward individuals is needed,
for example, preselection of the offered modules.
Third, the low usage of the program by patients in the
intervention group could have resulted in finding only a
significant effect on RAND-36 vitality, with a small effect size.
The low usage of the program can have several reasons. As
stated above, patients could have not felt a need for support.
Another reason could be that patients were not motivated to
change their behavior or had a negative attitude toward the
Web-based program. The program comprised several elements
to stimulate patients’ usage of the program, such as persuasive
texts or modeling videos. It could be that these elements did not
work or that elements were lacking in the program. Moreover,
the characteristics of the Web-based program, for example,
attractiveness or the ease of logging in, are factors that could
have influenced patient usage of the program. It was also notable
that patients in the intervention group dropped out more than
patients in the control group. A high dropout rate is a common
finding in Web-based programs [40,41]. Crutzen et al (2015),
gave as possible explanation for these higher dropout rates that
patients in an intervention group have several expectations of
the intervention. In cases where these expectations are not met
or if patients feel the intervention is not supporting them,
patients will refuse to fill in the measurements and will not
revisit the program [42]. In this study, patients in the intervention
group were significantly higher educated than in the control
group. It could be that higher educated patients use more
resources that could support them (eg, support of health
professionals), which could lead to lower usage of the program.
Fourth, this program was not adequately embedded in patient
care. Although nurses brought the program to the attention of
intervention group patients during their consultation, they did
not discuss the self-management topics of the program with
patients to continue the support for self-management during
consultations. It has been shown that self-management programs
with the possibility of interacting with health professionals
(blended care) can lead to positive results [14,43].
Fifth, it could be that there was a selection bias in this study.
Rheumatologists selected patients with diagnosis RA, aged 18
years, or were invited by letter to participate in this study, in
collaboration with rheumatologists until the required number
of 190 patients were reached. Probably, rheumatologists mainly
selected the patients who had a low functional disability (health
assessment questionnaire) as in their opinion, these patients
would benefit of a self-management program the most.
Recommendations
Given the results of this study, relevant recommendations for
future studies and practice can be given. First, using a
questionnaire with questions referring to the program objectives
is recommended to measure the effects in patient behavioral
change [38]. For example, one of the performance objectives
of this Web-based program, “set boundaries in their work
situation,” could be evaluated with an item like “I’m able to
set boundaries with my colleagues in my work situation”
(measuring skills). Patients can set their own objectives in the
program, using goal setting as a strategy. Goal setting requires
that patients set a clear, specific, and achievable goal to change
their behavior. This concrete formulation of the goal ensures
that the behavioral change is measurable [44].
Second, before inclusion, it is recommended to investigate
whether patients have a need for self-management support and
if so, what kind of support they need. A next step is to decide
if patient support needs are handled in the program and to tailor
the program to their support needs. This can avoid patients
feeling that the program did not support them, which often
results in no revisits. Investigation of support needs could take
place over the telephone. This also offers the possibility of
J Med Internet Res 2019 | vol. 21 | iss. 4 | e12463 | p.12https://www.jmir.org/2019/4/e12463/
(page number not for citation purposes)
Zuidema et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
helping patients formulate their support needs, which is difficult
to do in general.Third, to increase the usage of the program and
limit dropout, during the development phase, it is important to
pay attention to factors that could enhance usage of the program
(first visit, staying on the website, revisits).Patients input, in
combination with attention to dissemination, reach, adoption
and implementation (emphasized in diffusion theory or RE-AIM
theory), could be used to identify factors [45,46]. Moreover,
qualitative research to explore the reasons for low usage should
be conducted.
Fourth, to embed the program in regular health care, it is
important that patient needs are also recognized by their
rheumatologists or specialized rheumatology nurse and be used
as a starting point during consultation. Nurses could also assist
patients in performing exercises mentioned in the program,
reminding patients to log on to the website and encourage
patients to maintain their self-management behavior. Fifth, to
increase the usage and efficacy of the program, a specific patient
selection is needed. Further research is needed to assess which
patient characteristics influence the use of a Web-based program
and the outcomes, for example, by performing subgroup analysis
among groups with a low or high functional disability or by
assessing their level of motivation to use the program. This can
determine which inclusion criteria should be used to select
patients likely to benefit most.
Conclusions
In conclusion, although there is external evidence in favor of
the efficacy of Web-based self-management interventions
[14,15], it is not recommended to conduct a larger trial yet. As
advised by the MRC framework, a detailed process evaluation
of the program should be conducted to gain thorough insight
into the implementation of the program, the working elements
of the program and the usage of the program by patients, which
could be both important conditions for the success of a
self-management program. This could also satisfy the need for
attention to the usage and the perceived impact of the program
to find out for whom this sort of program will work [47].
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